With 0.22 million shares changed hands, the volume of the stock remained heavier than its average volume of 66950.0 shares. During the session, the Scientific & Technical Instruments company that operates in wider Technology sector, reached to the highest price of $95.17 whereas the lowest price it dropped to was $91.62. The 52-week range on MLAB shows that it touched its highest point at $155.12 and its lowest point at $83.68 during that stretch. It currently has a 1-year price target of $121.67. With its current market cap of 507.30 million, MLAB has annualized dividend of $0.64 while the current yield stands at 0.69%. MLAB paid its most recent dividend on 1748563200, while the ex-dividend date for that was 1748563200. Beta for the stock currently stands at 0.89.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MLAB was down-trending over the past week, with a drop of -11.02%, but this was down by -21.56% over a month. Three-month performance dropped to -25.15% while six-month performance fell -27.11%. The stock gained 1.52% in the past year, while it has lost -29.48% so far this year. A look at the trailing 12-month EPS for MLAB yields -0.37 with Next year EPS estimates of 9.45. For the next quarter, that number is 2.27. This implies an EPS growth rate of -17.35% for this year and 9.21% for next year.
Float and Shares Shorts:
At present, 5.46 million MLAB shares are outstanding with a float of 5.32 million shares on hand for trading. On 2025-05-30, short shares totaled 0.18 million, which was 336.0 higher than short shares on 1745971200. In addition to Mr. Gary M. Owens as the firm’s CEO, President & Director, Mr. John V. Sakys CPA serves as its VP, CFO & Chief Accounting Officer.
Institutional Ownership:
Through their ownership of 0.96444 of MLAB’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, MLAB reported revenue of $62135000.0 and operating income of $1469000.0. The EBITDA in the recently reported quarter was $10477000.0 and diluted EPS was $nan.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MLAB since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With MLAB analysts setting a high price target of 140.0 and a low target of 100.0, the average target price over the next 12 months is 121.66667. Based on these targets, MLAB could surge 50.55% to reach the target high and rise by 7.54% to reach the target low. Reaching the average price target will result in a growth of 30.84% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $7.74249 being high and $7.66809 being low. For MLAB, this leads to a yearly average estimate of $7.70333.
